Yasmin B. Kassam
McMaster University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasmin B. Kassam.
Seminars in Arthritis and Rheumatism | 1987
Jonathan D. Adachi; W. Bensen; Yasmin B. Kassam; Peter Powers; Fernando A. Bianchi; Alfred Cividino; Walter F. Kean; Patrick J. Rooney; Gary L. Craig; W. Watson Buchanan; Peter Tugwell; Duncan A. Gordon; Anne Lucarelli; Dharam P. Singal
Gold induced thrombocytopenia is immune mediated, with the production of platelet associated IgG leading to peripheral platelet destruction. An association with HLA-DR3 has been demonstrated. Corticosteroid therapy is effective in treatment, although other modes of therapy may be as efficacious.
Current Medical Research and Opinion | 1985
Eileen M. Grace; Nicholas Bellamy; Yasmin B. Kassam; W. Watson Buchanan
Thirty-six patients with definite or classical rheumatoid arthritis participated in a double-blind, randomized, placebo-controlled trial to assess the effectiveness of adding amitriptyline to the treatment regimen for the relief of pain not adequately controlled by non-steroidal anti-inflammatory drugs. Dosage of amitriptyline was increased gradually up to 25 mg 3-times daily and patients were followed up for 12 weeks. Assessments were made of joint pain and tenderness every 4 weeks. The results showed no difference between the amitriptyline and placebo-treated patients for either parameter.
Journal of the American Geriatrics Society | 1984
Peter Brooks; Walter F. Kean; Yasmin B. Kassam; W. Watson Buchanan
Rheumatic diseases are prevalent in the elderly population, resulting in high morbidity caused mainly by lack of mobility. Consequently, the use of antirheumatic drugs in older persons is extensive. This review outlines some of the hazards encountered in the use of antirheumatic drugs in the elderly. Analgesics such as propoxyphene and acetaminophen are useful adjuncts to the treatment of arthritic pain, but propoxyphene has been associated with respiratory depression, and renal clearance of acetaminophen is reduced in elderly subjects. Salicylates may cause deafness, and like the other nonsteroidal anti‐inflammatory drugs, may cause salt and water retention resulting in congestive cardiac failure. Phenylbutazone should not be used because of the risk of blood dyscrasia, and indomethacin has been reported as interfering with the antihypertensive effect of β‐blockers. Chloroquine levels may be raised in patients with impaired renal function, and there is increased risk of retinal damage with the drug in elderly subjects. Injectable gold compounds and penicillamine are not contraindicated in the elderly, because they are just as efficacious as in younger persons for the treatment of rheumatoid arthritis. Toxicity due to gold compound is not increased in the elderly, but skin rashes and abnormalities of taste do occur more commonly in elderly patients treated with penicillamine. Corticosteroids do not affect disease progression and therefore should be used only in acute severe disease for short periods of time. As in the younger population, treatment of gout in the elderly is dependent on renal function. The treatment of rheumatic diseases in the elderly requires careful consideration of the metabolic consequences before a regimen of drug therapy is introduced. Properly managed drug therapy in the elderly arthritic patient will result in considerable improvement in mobility, thus greatly enhancing the quality of life.
Clinical Pharmacology & Therapeutics | 1984
Walter F. Kean; Yasmin B. Kassam; C. J. L. Lock; W. Watson Buchanan; Janice Rischke; L Nablo
Gold sodium thiomalate has been shown to inhibit serine esterase enzymes isolated from the lysosomes of white cells. We demonstrate for the first time to our knowledge that gold sodium thiomalate is inhibitory to the serine esterase thrombin in its interaction with washed human platelets, human platelet‐rich plasma, and human platelet‐poor plasma. Since thrombin is a serine esterase phylogenetically related to the serine esterases elastase and cathepsin G, the most likely mechanism of action is an interaction of the gold thiol complex with one or all of the four cysteine–cysteine disulfide bridges of the thrombin molecule.
Inflammopharmacology | 1992
Yasmin B. Kassam; Walter F. Kean; C. J. L. Lock; G. T. Simon; W. Watson Buchanan
We have studied the distribution of gold in platelets from patients with rheumatoid arthritis (RA) undergoing chrysotherapy and, in vitro, in platelets reacted with gold sodium thiomalate. In vitro, electron dense fibrillar particles within membrane bound structures were detected in preparations containing 50 μg/ml or more of Au. Energy dispersive spectroscopy confirmed the presence of gold and sulphur in these particles. Gold was detected in platelets from RA patients by neutron activation analysis, but not by electron microscopy.
Seminars in Arthritis and Rheumatism | 1985
Walter F. Kean; F. Forestier; Yasmin B. Kassam; W. Watson Buchanan; Patrick J. Rooney
Rheumatology | 1988
Eileen M. Grace; Erika M. Gerecz; Yasmin B. Kassam; Helen M. Buchanan; W. Watson Buchanan; Peter Tugwell
The Lancet | 1988
D.P. Singal; W. Bensen; Yasmin B. Kassam
Journal of Pharmaceutical Sciences | 1988
Walter F. Kean; C. J. L. Lock; Dharam P. Singal; Yasmin B. Kassam; Helen Elaine Howard-Lock; Janice Rischke
Rheumatology | 1986
R. Magder; Mary Lou Baxter; Yasmin B. Kassam